DE69123099T2 - Vibrio-produzierte Protease enthaltende Zusammensetzungen und Verfahren zur Verwendung in Debridement und Wundheilung - Google Patents

Vibrio-produzierte Protease enthaltende Zusammensetzungen und Verfahren zur Verwendung in Debridement und Wundheilung

Info

Publication number
DE69123099T2
DE69123099T2 DE69123099T DE69123099T DE69123099T2 DE 69123099 T2 DE69123099 T2 DE 69123099T2 DE 69123099 T DE69123099 T DE 69123099T DE 69123099 T DE69123099 T DE 69123099T DE 69123099 T2 DE69123099 T2 DE 69123099T2
Authority
DE
Germany
Prior art keywords
protease
image
vibrio
iii
debridement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69123099T
Other languages
English (en)
Other versions
DE69123099D1 (de
Inventor
Donald Zane Fortney
Donald Richard Durham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WR Grace and Co Conn
WR Grace and Co
Original Assignee
WR Grace and Co Conn
WR Grace and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/567,884 external-priority patent/US5145681A/en
Application filed by WR Grace and Co Conn, WR Grace and Co filed Critical WR Grace and Co Conn
Application granted granted Critical
Publication of DE69123099D1 publication Critical patent/DE69123099D1/de
Publication of DE69123099T2 publication Critical patent/DE69123099T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/63—Vibrio
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio
DE69123099T 1990-08-15 1991-07-29 Vibrio-produzierte Protease enthaltende Zusammensetzungen und Verfahren zur Verwendung in Debridement und Wundheilung Expired - Lifetime DE69123099T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/567,884 US5145681A (en) 1990-08-15 1990-08-15 Compositions containing protease produced by vibrio and method of use in debridement and wound healing
US67061291A 1991-03-13 1991-03-13

Publications (2)

Publication Number Publication Date
DE69123099D1 DE69123099D1 (de) 1996-12-19
DE69123099T2 true DE69123099T2 (de) 1997-03-06

Family

ID=27074608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123099T Expired - Lifetime DE69123099T2 (de) 1990-08-15 1991-07-29 Vibrio-produzierte Protease enthaltende Zusammensetzungen und Verfahren zur Verwendung in Debridement und Wundheilung

Country Status (10)

Country Link
US (1) US5505943A (de)
EP (1) EP0472011B1 (de)
JP (1) JP3253108B2 (de)
AT (1) ATE145139T1 (de)
CA (1) CA2046802C (de)
DE (1) DE69123099T2 (de)
DK (1) DK0472011T3 (de)
ES (1) ES2094171T3 (de)
GR (1) GR3022412T3 (de)
NZ (1) NZ238954A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202017000266U1 (de) 2017-01-18 2017-03-29 Norbert Neubauer Debridement - Vorrichtung zur Wundheilung
DE202018002112U1 (de) 2018-04-26 2018-05-25 Norbert Neubauer Wund-Spül-Saugstab

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840836A (en) * 1989-02-17 1998-11-24 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US6811989B1 (en) * 1989-02-17 2004-11-02 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
EP0661293A3 (de) * 1993-12-29 1999-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Protein mit Zellwachstumsstimulierender und Makrophage chemotaktischer Wirkung, Verfahren zur Herstellung und Verwendung
GB9502120D0 (en) * 1995-02-03 1995-03-22 Chiroscience Ltd Purified enzyme and its preparation
US6017531A (en) * 1997-06-02 2000-01-25 W. R. Grace & Co. Hydrophilic composition containing protease produced by Vibrio
WO2000041714A1 (en) * 1999-01-19 2000-07-20 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
US7184963B1 (en) 1999-01-19 2007-02-27 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
US20040110669A1 (en) * 2001-05-16 2004-06-10 Kakkis Emil D. Destruction of prions using vibriolysin or variants thereof
US7223386B2 (en) * 2002-03-11 2007-05-29 Dow Corning Corporation Preparations for topical skin use and treatment
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US7332179B2 (en) * 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US20050244480A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Pre-wipes for improving anal cleansing
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US20060140899A1 (en) * 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. Skin cleansing system comprising an anti-adherent formulation and a cationic compound
US7642395B2 (en) * 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
EP2197409A1 (de) * 2007-08-31 2010-06-23 DSM IP Assets B.V. 4-amidino-benzylamine für kosmetische und/oder dermatologische anwendungen
WO2009089368A1 (en) * 2008-01-08 2009-07-16 Tufts University Wound healing peptides and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409719A (en) * 1967-05-23 1968-11-05 Baxter Laboratories Inc Debridement agent
US3677900A (en) * 1970-05-04 1972-07-18 Univ Lehigh Method of producing collagenase with a species of vibrio
US4329430A (en) * 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4276281A (en) * 1980-09-04 1981-06-30 Crikelair George F Burn treatment
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4966846A (en) * 1987-10-01 1990-10-30 W. R. Grace & Co.-Conn. Molecular cloning and expression of a vibrio proteolyticus neutral protease gene
US4865983A (en) * 1987-12-04 1989-09-12 W. R. Grace & Co.-Conn. Cleaning compositions containing protease produced by vibrio and method of use
US5145681A (en) * 1990-08-15 1992-09-08 W. R. Grace & Co.-Conn. Compositions containing protease produced by vibrio and method of use in debridement and wound healing
EP0498532A1 (de) * 1991-01-10 1992-08-12 E.R. SQUIBB & SONS, INC. Proteolytische Enzyme enthaltende Puderzusammensetzung zur Entfernung von nekrotischem Gewebe

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202017000266U1 (de) 2017-01-18 2017-03-29 Norbert Neubauer Debridement - Vorrichtung zur Wundheilung
DE202018002112U1 (de) 2018-04-26 2018-05-25 Norbert Neubauer Wund-Spül-Saugstab

Also Published As

Publication number Publication date
DK0472011T3 (da) 1996-12-02
CA2046802C (en) 2007-05-22
DE69123099D1 (de) 1996-12-19
EP0472011A1 (de) 1992-02-26
JP3253108B2 (ja) 2002-02-04
ES2094171T3 (es) 1997-01-16
US5505943A (en) 1996-04-09
ATE145139T1 (de) 1996-11-15
GR3022412T3 (en) 1997-04-30
JPH05178761A (ja) 1993-07-20
CA2046802A1 (en) 1992-02-16
EP0472011B1 (de) 1996-11-13
NZ238954A (en) 1993-09-27

Similar Documents

Publication Publication Date Title
DE69123099T2 (de) Vibrio-produzierte Protease enthaltende Zusammensetzungen und Verfahren zur Verwendung in Debridement und Wundheilung
US10206982B2 (en) Wound debridement compositions containing seaprose and methods of wound treatment using same
DE69429450T2 (de) Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
US20030105063A1 (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
ES2088006T3 (es) Composiciones farmaceuticas osteoinductivas.
DE69605544D1 (de) Peptidverbindungen mit wachstumsfaktorähnlicher aktivität
CA2307638A1 (en) Multiply-substituted protease variants
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
ATE321141T1 (de) Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines chymotrypsinhemmstoffes zum zellkulturmedium
EP0824910A3 (de) Verwendung eines Krill-Enzyms zur Behandlung von Zahnbelag
AU5125693A (en) Dorsal tissue affecting factor and compositions
AU5761499A (en) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
TW272974B (de)
US4276281A (en) Burn treatment
BR0107544A (pt) Composição de promoção de secreção de bile
Peacock Collagenolysis: The other side of the equation
CA1077837A (en) Hydrolytic enzyme material
Vanscheidt et al. Types of enzymes on the market
DE69509657D1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
WO2002049642A3 (en) Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis
CO4560484A1 (es) Composiciones polimericas antiestaticas de ionomeros y/o copolimero de olefina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition